Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Preferred Shares (2017)

Historic Preferred Shares for Northwest Biotherapeutics (NWBO) over the last 1 years, with Q4 2017 value amounting to $12.6 million.

  • Northwest Biotherapeutics' Preferred Shares changed N/A to $12.6 million in Q4 2017 from the same period last year, while for Dec 2017 it was $12.6 million, marking a year-over-year change of. This contributed to the annual value of $12.6 million for FY2017, which is N/A changed from last year.
  • As of Q4 2017, Northwest Biotherapeutics' Preferred Shares stood at $12.6 million.
  • Northwest Biotherapeutics' 5-year Preferred Shares high stood at $12.6 million for Q4 2017, and its period low was $12.6 million during Q4 2017.